Recommended Global Psychiatry Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Canada
MENTAL HEALTH CONGRESS-2026
- Welcome Message
- About Conference
- Sessions and Tracks
- Market Analysis
- Abstract Submission & Registration
- Past Conference
Welcome Message
We are delighted to welcome global researchers, clinicians, academicians, and mental health professionals to the 20th International Conference on Mental Health & Psychiatry, scheduled for September 14–15, 2026, in Barcelona, Spain. Guided by the theme “Uniting Global Minds to Strengthen Mental Health Systems,” this conference emphasizes the importance of collaborative innovation in addressing complex psychiatric challenges.
The scientific program will explore emerging insights into brain function, behavioral health, and systemic influences such as insulin resistance, which are increasingly recognized for their role in mental well-being. Discussions will also examine how conditions linked with glucose metabolism influence cognitive and emotional health outcomes. Advanced research on neurobiological mechanisms, including the impact of hyperglycemia on neural pathways, will be highlighted across sessions.
Through keynote lectures, panel discussions, and interactive workshops, participants will engage with cutting-edge developments shaping the future of psychiatry. Special focus will be given to interdisciplinary approaches, integrating biological, psychological, and social dimensions, including factors such as metabolic dysregulation that intersect with mental health.
We look forward to welcoming you to Barcelona for a dynamic and enriching scientific exchange that fosters innovation, collaboration, and progress in global mental health systems.
Target Audience
- Psychiatrists
- Clinical Psychologists
- Neurologists
- Mental Health Counsellors
- Behavioral Scientists
- Psychotherapists
- Psychiatric Nurses
- Neurobiologists
- Public Health Professionals
- Social Workers
- Academic Researchers & Faculty
- Healthcare Practitioners
- Rehabilitation Specialists
- Policy Makers in Mental Health
- Pharmaceutical & Healthcare Industry Professionals
- Digital Health & AI Experts
- Graduate Students
- Postgraduate Trainees
- PhD Scholars
- Clinical Fellows & Residents
About Conference
The 20th International Conference on Mental Health & Psychiatry, taking place on September 14–15, 2026, in Barcelona, Spain, is a premier global platform dedicated to advancing research, innovation, and clinical practice in mental health. Anchored by the theme “Uniting Global Minds to Strengthen Mental Health Systems,” the conference highlights the need for integrated and collaborative approaches to psychiatric care.
The scientific agenda spans a broad spectrum of topics, including neurobiology, psychotherapy, digital psychiatry, and public mental health. Emerging evidence linking physiological conditions such as glycemic variability with psychological disorders will be explored, along with the role of insulin signaling pathways in brain function. Sessions will also address the growing impact of lifestyle-related conditions like metabolic syndrome on emotional and cognitive health.
Participants will gain insights into advanced diagnostic tools, innovative therapeutic strategies, and multidisciplinary care models. The conference also emphasizes the importance of early intervention and preventive approaches, considering biological markers such as beta-cell dysfunction that may influence mental health outcomes.
Through keynote sessions, expert panels, workshops, and poster presentations, this conference fosters collaboration among global experts and promotes the translation of research into clinical excellence.
Why to Attend
The 20th International Conference on Mental Health & Psychiatry offers a unique opportunity to engage with global leaders in psychiatry and mental health research. Over two intensive days, participants will explore innovative approaches to diagnosis, treatment, and prevention of mental health disorders.
The conference provides valuable insights into interdisciplinary research, including the relationship between mental health and physiological conditions such as glucose intolerance, which can influence emotional stability. Attendees will also learn about advancements in therapeutic strategies addressing factors like insulin sensitivity and their impact on brain health.
This event serves as a platform to exchange ideas, build professional networks, and collaborate on future research initiatives. Discussions will highlight the integration of technology, personalized medicine, and holistic care approaches, including understanding systemic influences such as endocrine imbalance.
Whether you are a clinician, researcher, or healthcare professional, this conference enables you to stay updated with the latest developments while enhancing your expertise in modern psychiatric care.
Conference Highlights
-
Global Mental Health Leaders on One Platform:
Engage with internationally recognized psychiatrists, researchers, and clinicians shaping modern mental healthcare systems worldwide.
-
Advanced Workshops & Clinical Sessions:
Participate in expert-led sessions focusing on psychotherapy, neurobiology, and innovative treatment approaches influenced by factors such as glycemic control.
-
Scientific Sessions on Emerging Research:
Explore cutting-edge topics including digital psychiatry, brain imaging, and interdisciplinary studies examining links with insulin regulation and mental health outcomes.
-
Mental Health Technology & Innovation Showcase:
Discover advanced tools, AI-based mental health solutions, and digital healthcare technologies transforming psychiatric care delivery.
-
Young Researchers & Early Career Forum:
A dedicated platform for students, researchers, and fellows to present work, gain feedback, and build international exposure.
-
Networking & Global Collaboration:
Connect with professionals across disciplines to foster research collaborations and knowledge exchange.
-
Awards for Scientific Excellence:
Recognition for outstanding contributions through Best Research Presentation, Young Investigator Award, Best Poster, and Clinical Innovation Awards.
Sessions and Tracks
Track 1: Neurobiological Foundations of Mental Disorders
Advancements in neuroscience reveal how structural and functional brain alterations influence psychiatric conditions. Variations in neurotransmitter signaling affect cognition, mood, and behavioral responses. Chronic stress reshapes neural circuits, sometimes linked with systemic conditions like insulin resistance that influence brain health. Brain imaging technologies enable early detection of abnormalities such as hyperglycemia-related cognitive decline. These insights support targeted therapeutic interventions, especially when cellular damage like beta-cell dysfunction and fluctuating glycemic variability indirectly affect neural stability.
Research Focus Areas:
- Neural Circuit Dysregulation
- Neurotransmitter Imbalance Models
- Brain Imaging Correlates
Track 2: Psychotherapy Innovations & Behavioral Interventions
Modern psychotherapy integrates cognitive, emotional, and behavioral strategies to improve patient outcomes. Therapists are refining techniques for complex mental health conditions influenced by lifestyle disorders like metabolic syndrome. Digital platforms enhance accessibility while addressing challenges such as glucose intolerance that may affect emotional stability. Personalized approaches improve engagement, particularly in individuals with altered insulin sensitivity.
Therapeutic Pathways:
- Cognitive Therapy Advancements
- Behavioral Modification Techniques
- Digital Mental Health Tools
Track 3: Psychiatric Epidemiology & Public Health
Epidemiological studies analyze the distribution of mental disorders globally. Social determinants strongly influence outcomes, especially in populations with conditions like elevated fasting plasma glucose. Identifying high-risk groups enables preventive interventions, including those with high glycated hemoglobin levels. Public health strategies also consider complications such as diabetic neuropathy affecting quality of life.
Population Insights:
- Risk Distribution Analysis
- Preventive Health Models
- Community Mental Health Planning
Track 4: Child & Adolescent Psychiatry
Early-life mental health shapes long-term psychological well-being. Developmental stages influence emotional and cognitive growth patterns, often interacting with biological factors like insulin secretion. Environmental triggers combined with metabolic conditions affecting glucose uptake may alter behavior. Pediatric care also examines endocrine influences linked to the endocrine pancreas.
Developmental Perspectives:
- Early Disorder Indicators
- Pediatric Intervention Models
- Family-Centered Care
Track 5: Geriatric Psychiatry & Cognitive Decline
Aging populations face increased risks of cognitive and emotional disorders. Neurodegenerative diseases often coexist with metabolic conditions like type 2 diabetes mellitus. Memory loss and mood disturbances may worsen due to disrupted glucose homeostasis. Advanced treatments consider the role of insulin analogs in systemic balance. Cellular aging processes such as beta-cell apoptosis indirectly influence mental health outcomes.
Aging Care Models:
- Dementia Management
- Cognitive Decline Assessment
- Integrated Elderly Support
Track 6: Stress, Anxiety & Trauma Disorders
Chronic stress significantly impacts mental stability and physiological balance. Anxiety disorders often arise alongside hormonal changes like altered glucagon secretion. Neuroendocrine responses influence emotional regulation and may increase hepatic glucose output during stress. Trauma-informed care incorporates biological insights including insulin receptor signaling. Dietary and lifestyle factors affecting glycemic load also contribute to stress resilience.
Stress Response Systems:
- Trauma Recovery Approaches
- Anxiety Regulation Methods
- Neuroendocrine Analysis
Track 7: Addiction Psychiatry & Substance Use Disorders
Substance use disorders alter brain reward pathways and behavioral responses. Addiction research explores links between metabolic disruptions such as diabetic ketoacidosis and psychological instability. Neurochemical imbalances may worsen due to insulin deficiency. Severe addiction cases show metabolic shifts involving ketone bodies. Physiological stress responses, including metabolic acidosis, further complicate recovery.
Addiction Dynamics:
- Neurobiology of Dependence
- Rehabilitation Strategies
- Relapse Prevention Models
Track 8: Mood Disorders & Affective Neuroscience
Mood disorders involve complex interactions between biological and environmental factors. Depression is often linked with altered glucose metabolism. Hormonal imbalances influenced by adipokines can affect emotional stability. Disruptions in leptin signaling may influence mood regulation. Understanding pathways like insulin resistance pathways helps improve therapeutic outcomes.
Emotional Health Models:
- Mood Regulation Mechanisms
- Neurochemical Studies
- Therapy Innovations
Track 9: Schizophrenia & Psychotic Disorders
Psychotic disorders affect perception and cognition. Research highlights metabolic influences such as high glycemic index diets impacting brain function. Altered activity of glucose transporters affects neuronal energy supply. Genetic predisposition combined with insulin secretion defects increases vulnerability. Endocrine interactions play a role in psychiatric stability through endocrine regulation.
Clinical Evaluation Areas:
- Early Diagnosis Markers
- Genetic Risk Assessment
- Treatment Strategies
Track 10: Neurodevelopmental Disorders
Neurodevelopmental disorders impact cognitive and social functioning. Autism research explores biological markers including insulin-like growth factor. Cellular processes involving pancreatic beta cells may influence development. Brain energy usage linked to glucose oxidation affects cognition. Nutritional factors tied to carbohydrate metabolism also play a role.
Developmental Insights:
- Autism Spectrum Studies
- Cognitive Function Analysis
- Intervention Techniques
Track 11: Digital Psychiatry & Telehealth
Technology is transforming mental health care delivery systems. Telepsychiatry improves access, especially for patients managing glycemic excursions. Wearable devices track mental and physical health alongside continuous glucose sensors. AI-based systems integrate data from glucose monitoring systems. Advanced care includes managing patients using insulin pump therapy alongside therapy.
Technology Integration:
- AI-Based Diagnostics
- Telehealth Expansion
- Digital Monitoring Tools
Track 12: Psychopharmacology & Drug Development
Pharmacological treatments remain central to psychiatric care. Medication responses vary in individuals using oral hypoglycemic agents. Certain drugs interact with sulfonylureas, affecting outcomes. Treatment planning considers metabolic therapies like insulin therapy. Emerging research explores psychiatric effects of glucose lowering drugs.
Pharmacological Advances:
- Drug Mechanism Studies
- Clinical Trials
- Personalized Medicine
Track 13: Sleep Disorders & Mental Health
Sleep disturbances significantly impact psychological well-being. Insomnia may alter brain energy storage linked to glycogen storage. Hormonal balance influenced by insulin regulation affects sleep cycles. Liver activity such as hepatic metabolism plays a role in circadian rhythms. Night-time hormonal shifts involving glucagon pathways influence sleep quality.
Sleep Science Areas:
- Circadian Rhythm Research
- Sleep Disorder Diagnosis
- Treatment Methods
Track 14: Suicide Prevention & Crisis Intervention
Suicide prevention requires timely and structured interventions. Risk factors include chronic illness such as diabetic retinopathy impacting mental health. Emotional distress may worsen with hyperinsulinemia. Physiological imbalances like glucose dysregulation contribute to instability. Long-term risks increase with complications such as vascular complications.
Prevention Frameworks:
- Risk Identification
- Crisis Response
- Community Support
Track 15: Cultural Psychiatry & Social Influences
Cultural beliefs shape mental health perceptions and care approaches. Social factors influence outcomes in patients with insulin resistance syndrome. Hormonal balance involving pancreatic hormones affects emotional regulation. Lifestyle changes linked to metabolic dysregulation influence mental stability. Dietary impacts through glucose intolerance pathways also play a role.
Cultural Perspectives:
- Social Determinants
- Cross-Cultural Care
- Inclusive Practices
Track 16: Forensic Psychiatry & Legal Aspects
Forensic psychiatry examines the interface between mental health and law. Legal assessments consider physiological markers like glycemic thresholds. Drug interactions involving insulin pharmacokinetics may influence behavior. Nutritional factors affecting glucose absorption rates are evaluated. Hormonal balance through endocrine balance impacts psychological assessments.
Legal Considerations:
- Criminal Responsibility
- Risk Assessment
- Ethical Practice
Track 17: Women’s Mental Health & Hormonal Impact
Women’s mental health is influenced by hormonal changes across life stages. Conditions like postpartum depression relate to shifts in gestational diabetes. Hormonal imbalances affect emotional stability through insulin fluctuations. Pregnancy-related risks include glucose intolerance in pregnancy. Endocrine disruptions involving placental hormones influence mental health.
Women’s Health Focus:
- Hormonal Impact Studies
- Maternal Mental Health
- Gender-Specific Care
Track 18: Occupational Mental Health & Workplace Stress
Workplace stress affects productivity and psychological well-being. Chronic stress may increase risks of prediabetes markers. Sedentary lifestyles contribute to insulin resistance development. Occupational burnout is linked to poor health outcomes including glucose imbalance indicators. Corporate wellness programs address risks like metabolic health decline.
Workplace Strategies:
- Stress Management
- Employee Wellness Programs
- Productivity Enhancement
Track 19: Nutrition, Lifestyle & Mental Health
Diet and lifestyle significantly impact mental well-being. Poor nutrition contributes to disorders linked with postprandial glucose spikes. Balanced diets improve mood stability and reduce insulin demand fluctuations. Nutritional psychiatry examines links with dietary glycemic control. Lifestyle interventions help manage risks such as energy metabolism imbalance.
Lifestyle Approaches:
- Nutritional Interventions
- Preventive Care
- Behavioral Modifications
Track 20: Integrative & Holistic Mental Health Approaches
Holistic care integrates physical, psychological, and social well-being. Mind-body therapies consider biological factors like glucose homeostasis imbalance. Alternative therapies address stress and metabolic factors including insulin regulation cycles. Integrative care also targets cellular glucose utilization. Comprehensive approaches improve outcomes by managing metabolic stress responses.
Holistic Care Models:
- Mind-Body Integration
- Alternative Therapies
- Preventive Health Strategies
Market Analysis
The global mental health and psychiatry market is experiencing significant growth due to rising awareness, increasing prevalence of mental disorders, and advancements in treatment approaches. Factors such as urbanization, lifestyle changes, and workplace stress are contributing to higher rates of anxiety, depression, and other psychiatric conditions.
Technological innovations like telepsychiatry, AI-based diagnostics, and digital therapeutics are transforming mental healthcare delivery. The integration of biological factors such as insulin resistance and glucose metabolism into psychiatric research is further expanding interdisciplinary approaches. Governments and healthcare organizations are also investing heavily in mental health infrastructure, policy reforms, and awareness campaigns.
The demand for personalized medicine is increasing, with research focusing on connections between physiological conditions like metabolic syndrome and mental health disorders. Additionally, rising cases of chronic conditions associated with hyperglycemia are influencing cognitive and emotional health, thereby driving the need for integrated care systems.
Overall, the market is expected to grow steadily, supported by innovation, policy support, and global collaboration in mental health systems.
Global Mental Health Market Growth (2020–2026):
The data shows a steady and consistent growth in the global mental health market from 2020 to 2026. The increase from USD 380 billion to USD 550 billion reflects rising awareness, improved diagnosis, and expanding access to mental healthcare services. Growth becomes more pronounced after 2023, largely due to the adoption of digital health technologies and telepsychiatry.
In addition, emerging research highlights the connection between mental health and physiological factors such as insulin resistance and glucose metabolism, which are influencing treatment approaches. The impact of chronic conditions associated with hyperglycemia and broader issues like metabolic syndrome are also contributing to the demand for integrated care. Overall, the market trend indicates strong future growth driven by innovation and global health priorities.
Distribution of Mental Health Disorders (%):
This data highlights the distribution of major mental health disorders, with anxiety (30%) and depression (28%) being the most prevalent globally. These conditions contribute significantly to the overall mental health burden and often require long-term management. Bipolar disorder and schizophrenia, though lower in percentage, represent serious conditions that need specialized treatment.
The “Others” category includes various psychological disorders that are increasingly being recognized. Recent studies also point to biological influences such as glycemic variability, insulin sensitivity, and glucose intolerance affecting mental health outcomes. Understanding these connections, along with factors related to endocrine regulation, is important for developing comprehensive and effective treatment strategies.
Abstract Submission & Registration
Researchers, psychiatrists, psychologists, academicians, clinicians, and healthcare professionals are invited to submit original scientific contributions to the 20th International Conference on Mental Health & Psychiatry, scheduled for September 14–15, 2026, in Barcelona, Spain. Submissions may include research abstracts, clinical studies, case reports, systematic reviews, poster presentations, or e-posters aligned with the conference theme and scientific tracks.
The conference encourages submissions exploring interdisciplinary perspectives, including biological influences such as insulin resistance on mental health. Authors may also present findings related to cognitive outcomes affected by glucose metabolism and associated behavioral changes. Research highlighting neuropsychiatric implications of systemic conditions like hyperglycemia is highly welcomed. Innovative studies integrating physiological and psychological dimensions, including metabolic dysregulation, will be given special consideration.
Abstract Guidelines
- All abstracts must be submitted in English.
- The abstract should not exceed 500 words.
- The title must be written in sentence case and clearly reflect the study focus.
- Provide full name, affiliation, and designation of the presenting author and all co-authors.
- Include a short biography of the presenting author (maximum 150 words) along with a professional photograph.
- Abstracts should align with conference tracks such as psychiatry, psychotherapy, neuroscience, public mental health, digital psychiatry, and related disciplines.
Review Process
All submitted abstracts will be evaluated by the Scientific Review Committee. Authors will receive notification regarding acceptance, revision, or rejection via email, typically within 24–48 hours of submission.
Accepted abstracts will be assigned for:
- Oral Presentations
- Poster Presentations
- Workshop Sessions
Selection will be based on scientific relevance, originality, and alignment with conference themes.
Publication
All accepted abstracts will be included in the official conference proceedings. Selected submissions may be considered for publication in associated international journals, conference compendiums, or mental health and psychiatry-focused publications.
Abstract Submission Link
https://mentalhealth.psychiatrycongress.com/abstract-submission.php
Registration
After abstract acceptance, participants are required to complete their registration through the official conference portal. Early registration is strongly recommended to secure participation in scientific sessions, workshops, networking opportunities, and certification.
https://mentalhealth.psychiatrycongress.com/registration.php
Visa Guidelines
The organizing committee of the 20th International Conference on Mental Health & Psychiatry 2026 does not directly process visas for Spain. However, we provide all necessary supporting documents to assist participants with their visa application process.
Applicants with health conditions such as glycemic variability or those undergoing treatment involving insulin therapy are advised to carry appropriate medical documentation during travel. Additionally, travelers managing chronic conditions related to glucose intolerance should ensure compliance with international travel health guidelines. Maintaining proper documentation for medications related to endocrine regulation is also recommended.
Documents Provided for Visa Support
Upon request, the following documents will be issued:
- Official Letter of Invitation
- Letter of Abstract Acceptance
- Registration Confirmation and Payment Receipt
Visa Application Note
Visa requirements vary depending on your country of residence and the regulations of the Spanish Embassy or Consulate. Participants are strongly advised to apply well in advance of the conference dates to avoid delays.
Letter of Invitation
The Letter of Invitation confirms your abstract acceptance and/or completed registration for the conference. This document is issued in English and can be used as supporting documentation for your visa application.
Please note that issuance of an invitation letter does not guarantee visa approval. Visa decisions are made solely by the Spanish immigration authorities and respective embassies or consulates.
Contact for Visa Support
For visa-related assistance or to request official supporting documents, please contact:
[email protected]
Past Conference
Conference Overview
The 2025 edition of the conference brought together global experts in psychiatry, psychology, neuroscience, and mental health research. It served as an international platform for presenting scientific research, exchanging knowledge, and fostering collaboration among healthcare professionals and researchers.
The event emphasized interdisciplinary approaches, encouraging both empirical and conceptual contributions from academia and industry. It provided a structured environment where participants could explore innovative ideas, share research findings, and gain exposure to diverse methodologies in mental health and psychiatry.
Scientific Program & Participation
- Included oral presentations and poster presentations
- Abstracts were peer-reviewed and published with DOI indexing
-
Participants included professionals from multiple regions such as:
- Asia-Pacific
- Europe
- Americas
The conference encouraged active interaction between speakers and attendees, promoting knowledge exchange and research collaboration.
Key Features & Highlights
- Platform for global networking and collaborations
- Participation from researchers, clinicians, and industry professionals
- High engagement, with 80% attendees visiting exhibitor booths multiple times
- Opportunities for organizing symposiums and scientific sessions
- Exposure to new research trends, tools, and techniques in psychiatry
To Collaborate Scientific Professionals around the World
Conference Date September 14-15, 2026
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by
